x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharma and BioTech Daily

Pharma and BioTech News

Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai

news tech news

All Episodes

5:00

Amneal's $1.1B Biosimilars Move & Merck's HIV Pill |...

Pharma and BioTech Daily ·

2026/04/23

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal events shaping the industry.Starting with Amneal Pharmaceuticals' strategic acquisition of Kashiv Biosciences for $1.1 billion, this move highlights what many are calling the "golden era" for biosimilars. These cost-effective alternatives to branded biologics are becoming increasingly crucial in expanding access to ...

en-us

4:57

Merck Welireg Fails, Roche Enspryng Shines in Trials...

Pharma and BioTech Daily ·

2026/04/22

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore some of the pivotal shifts and breakthroughs shaping the industry and their implications for drug development and patient care.In oncology, Merck & Co.'s Welireg triplet therapy faced a setback in its Phase 3 trial for first-line treatment of kidney cancer. Despite previous successes, this outcome underscores the complexity of developing ...

en-us

5:10

Eli Lilly's $7B Kelonia Buy Boosts CAR-T Tech |...

Pharma and BioTech Daily ·

2026/04/21

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal advancements and strategic moves that are reshaping the landscape of drug development and patient care. In vaccine development, Sanofi has recently reported promising results from a comparative trial of its protein-based COVID-19 vaccine, Nuvaxovid, against Moderna’s latest mRNA vaccine, MNEXspike. The focus here was...

en-us

5:19

Kailera IPO Raises $625M for Obesity Drug | Pharma...

Pharma and BioTech Daily ·

2026/04/20

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore China's burgeoning role in the synthetic biology sector, as outlined in a recent article discussing China's strategic focus on biotechnology within its latest five-year plan. This strategy identifies biomanufacturing, particularly synthetic biology and genetic engineering, as pivotal for China's emerging bioeconomy. The nation's approach frame...

en-us

4:49

Gene Therapy Setbacks and Strategic Shifts in Biotech

Pharma and BioTech Daily ·

2026/04/17

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. This week, we delve into a series of compelling stories that are shaping the future of drug development, therapeutic innovation, and patient care. The gene therapy sector is currently under the spotlight, with Johnson & Johnson handing back the rights to botaretigene sparoparvovec to MeiraGTx following a phase 3 trial failure. This underscores the inherent ...

en-us

6:03

AI Integration and Regulatory Shifts in Pharma

Pharma and BioTech Daily ·

2026/04/16

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're exploring a fascinating realm where technology and biology converge, starting with a deepening relationship between biopharma and artificial intelligence.Novartis CEO Vas Narasimhan's recent appointment to the board of AI company Anthropic signals the strategic integration of AI into drug discovery and development processes. This collaboration hig...

en-us

4:23

AI Integration, FDA Milestones, and Strategic Shifts:...

Pharma and BioTech Daily ·

2026/04/15

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of transformative updates that reflect the dynamic landscape of our industry.Johnson & Johnson is making strategic moves in the immunology space, with Tremfya and the newly launched Icotyde playing pivotal roles in their portfolio. This development indicates J&J’s commitment to capturing a significant share of the immunolog...

en-us

5:10

Radiopharmaceuticals to CAR-T: Pharma's Cutting-Edge...

Pharma and BioTech Daily ·

2026/04/14

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most intriguing advancements and strategic moves shaping the future of drug development and patient care. Regeneron has recently ventured into the radiopharmaceuticals market through a substantial $2.1 billion agreement with Australia's Telix Pharmaceuticals. This move marks a significant diversification from Regeneron's traditi...

en-us

5:23

Biopunk Revolution: Reshaping Biotech Innovation

Pharma and BioTech Daily ·

2026/04/13

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the transformative potential of biopunk and community labs that are reshaping the biotechnology landscape. The biopunk movement, inspired by the punk music ethos, advocates for a more accessible, nimble, and innovative biotech future through grassroots initiatives. Elliot Roth, a serial biotech founder and community lab advocate, is chal...

en-us

4:50

Revolutionizing Pharma: Key Innovations and Strategic...

Pharma and BioTech Daily ·

2026/04/10

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of exciting and transformative updates shaping our industry.Let’s begin with the departure of a significant figure in pharmaceutical advocacy. Steven Ubl's exit as CEO of PhRMA marks a noteworthy change after over a decade at the helm. His leadership has been pivotal in advocating for policies that support pharmaceutical innov...

en-us

4:59

Navigating Breakthroughs: Pharma's Evolution in...

Pharma and BioTech Daily ·

2026/04/09

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of dynamic changes and strategic shifts reshaping these industries, driven by scientific advancements and regulatory updates.Let's start with Biogen, which recently resolved an investor lawsuit concerning its Alzheimer's drug, Aduhelm. Approved under controversial circumstances by the FDA, Aduhelm faced scrutiny for its efficacy a...

en-us

4:45

FDA's New Agenda & Gilead's Oncology Leap

Pharma and BioTech Daily ·

2026/04/08

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic moves shaping the ever-evolving landscape of drug development and patient care.The U.S. Food and Drug Administration, under Commissioner Marty Makary, is pursuing a comprehensive policy agenda as revealed in the fiscal year 2027 budget proposal to Congress. This agenda proposes a new c...

en-us

5:22

Pharma's Future: Mergers, Innovation, and AI

Pharma and BioTech Daily ·

2026/04/07

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of transformative events reshaping the industry as we know it. The pharmaceutical and biotech sectors are currently experiencing an unprecedented surge in mergers and acquisitions. This wave of consolidation is exemplified by Neurocrine Biosciences' substantial $2.9 billion acquisition of Soleno Therapeutics, marking a milestone as...

en-us

5:02

Navigating Biopharma's Strategic Shift: Key Developments

Pharma and BioTech Daily ·

2026/04/06

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the key changes shaping our industry, from a contraction in drug development pipelines to shifts in international trade policies, and what these might mean for the future of healthcare. Recent reports from Citeline indicate that for the first time in three decades, the R&D pipeline within biopharma is experiencing a contraction....

en-us

5:19

Immunotherapy Breakthroughs and Regulatory Shifts in...

Pharma and BioTech Daily ·

2026/04/03

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of remarkable advancements and challenges shaping these dynamic sectors.AstraZeneca has reported promising results with an immunotherapy combination involving Imfinzi (durvalumab) and Imjudo (tremelimumab) for treating locoregional liver cancer. This combination has demonstrated a significant progression-free survival benefit, pot...

en-us

4:43

Oral GLP-1 Breakthroughs and Strategic Biotech Shifts

Pharma and BioTech Daily ·

2026/04/02

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events shaping the industry, from groundbreaking drug approvals to strategic corporate maneuvers.Recently, the U.S. Food and Drug Administration (FDA) granted approval for Eli Lilly's new GLP-1 receptor agonist pill, Foundayoby, marking a significant milestone as it's the first new molecular entity to be cleare...

en-us

4:45

Pharma Giants Transforming Through Strategic...

Pharma and BioTech Daily ·

2026/04/01

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of noteworthy advancements and strategic movements shaping the future of drug development and patient care.The pharmaceutical industry is seeing a flurry of mergers and acquisitions, reflecting a strategic push to enhance therapeutic portfolios. Biogen's $5.6 billion acquisition of Apellis Pharmaceuticals emphasizes its ambition...

en-us

4:53

Biogen's SMA Breakthrough and AI's Rise in Pharma

Pharma and BioTech Daily ·

2026/03/31

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative developments that underscore the continual evolution of this dynamic industry.First, let's explore the latest strategic move from Takeda Pharmaceuticals, which has embarked on a $1.3 billion restructuring plan in the United States. This has resulted in layoffs affecting 634 employees, a decision aimed at stream...

en-us

5:02

Breakthroughs in COPD, CAR-T, and Gene Therapy

Pharma and BioTech Daily ·

2026/03/30

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.Today, we delve into recent significant advancements and strategic maneuvers reshaping the landscape in these dynamic industries. AstraZeneca has made a notable stride with its chronic obstructive pulmonary disease (COPD) drug candidate, achieving remarkable efficacy in Phase 3 trials. This success is particularly significant given the historical challenges in th...

en-us

4:56

Transformative FDA Approvals and Biotech Innovations

Pharma and BioTech Daily ·

2026/03/27

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the fast-paced changes shaping these sectors, focusing on the latest scientific breakthroughs, regulatory shifts, and industry trends.First off, Denali Therapeutics has achieved a significant milestone with FDA approval for its enzyme replacement therapy targeting Hunter syndrome, a rare genetic disorder. This therapy addresses neurological ...

en-us

543 results

Similar Podcasts

Expres Ráno

Expres FM

PBS News Hour - Full Show

PBS News

CD Voice

China Daily

Israel Today: Ongoing War Report

Noa Levi

Jeffrey Epstein: The Coverup Chronicles

Bobby Capucci